Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
DCPH was delisted on the 10th of June, 2024.
177 hedge funds and large institutions have $944M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 67 increasing their positions, 53 reducing their positions, and 14 closing their positions.
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
26% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 53
8% more funds holding
Funds holding: 164 → 177 (+13)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $972M → $944M (-$28.6M)
80% less call options, than puts
Call options by funds: $85K | Put options by funds: $434K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$10.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$9.67M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$9.23M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$7.62M |
| 5 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$6.68M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$47.6M |
| 2 |
DM
Deerfield Management
New York
|
-$10.2M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$8.62M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$6.39M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$5.39M |
DCPH Hedge Fund Activity: Q1 2024 in Review
177 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q1 2024, worth a combined $944M — down 2.9% from $972M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new DCPH positions and 14 closed out — a net gain of 13 holders — while 67 added to existing stakes and 53 trimmed.
The largest buyer was Armistice Capital, adding an estimated $10.8M. The largest seller was Morgan Stanley, cutting an estimated $47.6M.
- 177 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q1 2024, up from 164 in Q4 2023.
- Funds reported $944M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q1 2024, down 2.9% quarter-over-quarter.
- 27 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q1 2024 and 14 closed out, a net change of +13 holders.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q1 2024 was Armistice Capital, an estimated $10.8M added.
- The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q1 2024 was Morgan Stanley, an estimated $47.6M sold.
Based on aggregated 13F filings for Q1 2024.